{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:05:11Z","timestamp":1744517111375,"version":"3.40.4"},"reference-count":19,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.2176\/jns-nmc.2024-0269","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T22:08:16Z","timestamp":1744322896000},"page":"139-146","source":"Crossref","is-referenced-by-count":0,"title":["Favorable Response to Conventional Chemoradiotherapy in Radiation-induced Glioma Harboring Coamplification of PDGFRA, KIT, and KDR: A Case Report and Literature Review"],"prefix":"10.2176","volume":"12","author":[{"given":"Daisuke","family":"TANIKAWA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"SHIRAHATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kokyo","family":"SAKURADA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"FUKUOKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"MIZUNO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"SAKAKIBARA","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"KANEKO-MISHIMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"EHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"OZAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"SUZUKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"HOMMA","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"MISHIMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery\/Neuro-oncology, Saitama Medical University International Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Leary JB, Anderson-Mellies A, Green AL. Population-based analysis of radiation-induced gliomas after cranial radiotherapy for childhood cancers. Neurooncol Adv. 2022;4 (1):vdac159. doi: 10.1093\/noajnl\/vdac159","DOI":"10.1093\/noajnl\/vdac159"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Trkova K, Sumerauer D, Bubenikova A, et al. Clinical and molecular study of radiation-induced gliomas. Sci Rep. 2024;14 (1):3118. doi: 10.1038\/s41598-024-53434-0","DOI":"10.1038\/s41598-024-53434-0"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Paulino AC, Mai WY, Chintagumpala M, et al. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008;71 (5):1381-7. doi: 10.1016\/j.ijrobp.2007.12.018","DOI":"10.1016\/j.ijrobp.2007.12.018"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98 (21):1528-37. doi: 10.1093\/jnci\/djj411","DOI":"10.1093\/jnci\/djj411"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) DeSisto J, Lucas Jr JT, Xu K, et al. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat Commun. 2021;12 (1):5531. doi: 10.1038\/s41467-021-25709-x","DOI":"10.1038\/s41467-021-25709-x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Deng MY, Sturm D, Pfaff E, et al. Radiation-induced gliomas represent H3-\/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A\/B. Nat Commun. 2021;12 (1):5530. doi: 10.1038\/s41467-021-25708-y","DOI":"10.1038\/s41467-021-25708-y"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Whitehouse JP, Howlett M, Federico A, et al. Defining the molecular features of radiation-induced glioma: a systematic review and meta-analysis. Neurooncol Adv. 2021;3 (1):vdab109. doi: 10.1093\/noajnl\/vdab109","DOI":"10.1093\/noajnl\/vdab109"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) L\u00f3pez GY, Van Ziffle J, Onodera C, et al. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathol. 2019;137 (1):139-50. doi: 10.1007\/s00401-018-1906-z","DOI":"10.1007\/s00401-018-1906-z"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Disel U, Madison R, Abhishek K, et al. The pan-cancer landscape of coamplification of the tyrosine kinases KIT, KDR, and PDGFRA. Oncologist. 2020;25 (1):e39-47. doi: 10.1634\/theoncologist.2018-0528","DOI":"10.1634\/theoncologist.2018-0528"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Dono A, Ramesh AV, Wang E, et al. The role of <i>RB1<\/i> alteration and 4q12 amplification in IDH-WT glioblastoma. Neurooncol Adv. 2021;3 (1):vdab050. doi: 10.1093\/noajnl\/vdab050","DOI":"10.1093\/noajnl\/vdab050"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Cahan WG, Woodard HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1 (1):3-29. doi: 10.1002\/1097-0142(194805)1:1&lt;3::aid-cncr2820010103&gt;3.0.co;2-7","DOI":"10.1002\/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555 (7697):469-74. doi: 10.1038\/nature26000","DOI":"10.1038\/nature26000"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Sottoriva A, Spiteri I, Piccirillo SGM, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110 (10):4009-14. doi: 10.1073\/pnas.1219747110","DOI":"10.1073\/pnas.1219747110"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Carlotto BS, Trevisan P, Provenzi VO, et al. PDGFRA, KIT, and KDR gene amplification in glioblastoma: heterogeneity and clinical significance. NeuroMolecular Med. 2023;25 (3):441-50. doi: 10.1007\/s12017-023-08749-y","DOI":"10.1007\/s12017-023-08749-y"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Burford A, Little SE, Jury A, et al. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma. PLoS One. 2013;8 (8):e71777. doi: 10.1371\/journal.pone.0071777","DOI":"10.1371\/journal.pone.0071777"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yi S, Tsao MS. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia. 2000;2 (3):226-34. doi: 10.1038\/sj.neo.7900080","DOI":"10.1038\/sj.neo.7900080"},{"key":"17","unstructured":"17) Kwak Y, Kim SI, Park CK, et al. C-MET overexpression and amplification in gliomas. Int J Clin Exp Pathol. 2015;8 (11):14932-8."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Bhatia S, Bukkapatnam S, Van Court B, et al. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Mol Carcinog. 2020;59 (9):1064-75. doi: 10.1002\/mc.23237","DOI":"10.1002\/mc.23237"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Grogan PT, Helgager JJ, Deming DA, et al. Case report: radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: a report and molecular characterization of two unique cases. Front Neurol. 2023;14:1099424. doi: 10.3389\/fneur.2023.1099424","DOI":"10.3389\/fneur.2023.1099424"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0269\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:16:38Z","timestamp":1744431398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0269\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":19,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0269","relation":{},"ISSN":["2188-4226"],"issn-type":[{"type":"electronic","value":"2188-4226"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"article-number":"2024-0269"}}